ANL
Adlai Nortye GroupCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ANL vs peer average
69/100
ANL vs. peer average (C vs. D)
Grade spread
C 2 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Aligos is a loose small-cap biotech comp by size rather than mechanism; like ANL, valuation can swing sharply on clinical progress versus financing pressure.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANL
Adlai Nortye Group
ALGS
Aligos Therapeutics
Grade
C
D
Momentum
31
65
Value
46
41
Sentiment
58
53
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ALGS
ANL / ALGS
Grade Position
In line
ANL vs. peer average (C vs. D)
69/100
Momentum
31
ALGSValue
46
ANLSentiment
58
ANLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANL
ALGS is the first peer returned for this comparison set.